Paper · 2026 · Open access

Development and Evaluation of Nanolipid Carriers for Solubility Enhancement of Poorly Water-Soluble Drugs: A Comprehensive Review

Deepanshi Tyagi*, Zoobi Tahir, Saurabh Mishra, Vimal Kumar Singh

Zenodo (CERN European Organization for Nuclear Research) · Published 29 January 2026 · DOI 10.5281/zenodo.18414898

Read the free full textCite this paper

In brief

“Development and Evaluation of Nanolipid Carriers for Solubility Enhancement of Poorly Water-Soluble Drugs: A Comprehensive Review” is a 2026 paper by Deepanshi Tyagi*, Zoobi Tahir, Saurabh Mishra, Vimal Kumar Singh, published in Zenodo (CERN European Organization for Nuclear Research). OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Zenodo (CERN European Organization for Nuclear Research).

Citations
0
Authors
1

Abstract

Poor aqueous solubility continues to be one of the most formidable barriers in the development of new drug molecules, leading to poor dissolution, low bioavailability, and inconsistent therapeutic response. Approximately 40–60% of newly synthesized drug candidates fall under the category of poorly water-soluble compounds, belonging primarily to Biopharmaceutics Classification System (BCS) Class II and IV. Nanotechnology-based delivery systems, particularly Nanolipid Carriers (NLCs), have emerged as a highly effective approach for improving the solubility and oral absorption of such drugs. NLCs are the second generation of lipid nanoparticles, developed to overcome the limitations of Solid Lipid Nanoparticles (SLNs), offering higher drug loading, enhanced stability, and controlled release. This review provides a comprehensive overview of the development, formulation strategies, evaluation parameters, and applications of NLCs for solubility enhancement. Emphasis is placed on formulation design, optimization approaches, characterization techniques, and in vitro–in vivo correlations. The article also discusses toxicity, safety, and regulatory aspects of NLCs, highlighting their potential for clinical translation.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Singh, D. T. Z. T. S. M. V. K. (2026). Development and Evaluation of Nanolipid Carriers for Solubility Enhancement of Poorly Water-Soluble Drugs: A Comprehensive Review. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.18414898

MLA 9

Singh, Deepanshi Tyagi*, Zoobi Tahir, Saurabh Mishra, Vimal Kumar. “Development and Evaluation of Nanolipid Carriers for Solubility Enhancement of Poorly Water-Soluble Drugs: A Comprehensive Review.” Zenodo (CERN European Organization for Nuclear Research), 2026. https://doi.org/10.5281/zenodo.18414898.

Chicago

Singh, Deepanshi Tyagi*, Zoobi Tahir, Saurabh Mishra, Vimal Kumar. 2026. “Development and Evaluation of Nanolipid Carriers for Solubility Enhancement of Poorly Water-Soluble Drugs: A Comprehensive Review.” Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.18414898.

Harvard

Singh, D. T. Z. T. S. M. V. K. (2026) ‘Development and Evaluation of Nanolipid Carriers for Solubility Enhancement of Poorly Water-Soluble Drugs: A Comprehensive Review’, Zenodo (CERN European Organization for Nuclear Research). doi:10.5281/zenodo.18414898.

IEEE

D. T. Z. T. S. M. V. K. Singh, “Development and Evaluation of Nanolipid Carriers for Solubility Enhancement of Poorly Water-Soluble Drugs: A Comprehensive Review,” Zenodo (CERN European Organization for Nuclear Research), 2026, doi: 10.5281/zenodo.18414898.

BibTeX

@article{singh2026development,
  title     = {{Development and Evaluation of Nanolipid Carriers for Solubility Enhancement of Poorly Water-Soluble Drugs: A Comprehensive Review}},
  author    = {Singh, Deepanshi Tyagi*, Zoobi Tahir, Saurabh Mishra, Vimal Kumar},
  journal   = {Zenodo (CERN European Organization for Nuclear Research)},
  year      = {2026},
  doi       = {10.5281/zenodo.18414898},
  url       = {https://doi.org/10.5281/zenodo.18414898}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems

  • poorly water-soluble drugs
  • solubility enhancement
  • lipid nanoparticles
  • solid lipid nanoparticles
  • BCS Class II and IV drugs
  • oral bioavailability
  • drug dissolution
  • formulation optimization

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Singh, D. T. Z. T. S. M. V. K. (2026). Development and Evaluation of Nanolipid Carriers for Solubility Enhancement of Poorly Water-Soluble Drugs: A Comprehensive Review. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.18414898

How many times has this paper been cited?

0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Zenodo (CERN European Organization for Nuclear Research).

Who wrote this paper?

Deepanshi Tyagi*, Zoobi Tahir, Saurabh Mishra, Vimal Kumar Singh.

What is the DOI of this paper?

10.5281/zenodo.18414898. The permanent link is https://doi.org/10.5281/zenodo.18414898.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.